Available now: AltoStar® HAV RT-PCR Kit 1.5
altona Diagnostics has launched the CE marked AltoStar® HAV RT-PCR Kit 1.5, an in vitro diagnostic test based on real-time RT-PCR technology for the qualitative detection of hepatitis A virus (HAV) specific RNA in human plasma. It is designed for use with the AltoStar® Molecular Diagnostic Workflow, which offers enhanced flexibility in sample-to-PCR management. The kit is intended to be used as an aid for the diagnosis of an HAV infection.
Hepatitis is an acute or chronic inflammation of the liver. One of the main causes of hepatitis are infections with one of the five phylogenetically unrelated hepatitis viruses A, B, C, D and E. While HAV and HEV cause transient, acute infections, over 325 million people worldwide live with a chronic Hepatitis B and/or C infection.
Hepatitis A virus (HAV) is an RNA virus that is mainly transmitted through contaminated food or water or through close contact with an infected person. HAV infections never become chronic and almost all people fully recover and establish a lifelong immunity. Nevertheless, some patients die from fulminant hepatitis. There is a vaccine available to prevent HAV infections.
altona Diagnostics now provides four different AltoStar® ready-to-use test kits for the detection of acute and chronic viral hepatitis. These CE IVD marked AltoStar® reagents are intended for use as part of the AltoStar® Molecular Diagnostic Workflow which automates infectious disease testing from sample extraction to PCR results. The AltoStar® Automation System AM16, a pipetting workstation, in combination with the AltoStar® Connect software, is the centerpiece of the AltoStar® Workflow.